ArticleBreast cancer research : BCR2026

HSP90AA1-VDAC1 interaction contributes to breast cancer progression and doxorubicin resistance through PI3K/AKT signaling.

Yutong Fang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.